Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 12, 2012, Pages

  White, Donna L ^a   Kanwal, Fasiha ^a   El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HCV.; Insulin Resistance; Neoplasm; Obesity; Risk Factor

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; OBESITY; REVIEW; SYSTEMATIC REVIEW;

EID: 84869436442     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.10.001     Document Type: Article

References (69)

1. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817-823.
2. El-Serag H.B. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007, 37(Suppl 2):S88-S94.
3. Adams L.A., Lindor K.D. Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17:863-869.
4. Musso G., Gambino R., Cassader M., et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011, 43:617-649.
5. Lazo M., Hernaez R., Bonekamp S., et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011, 343:d6891.
6. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
7. Sorensen H.T., Friis S., Olsen J.H., et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998, 28:921-925.
8. Sanyal A., Poklepovic A., Moyneur E., et al. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010, 26:2183-2191.
9. Ong J.P., Pitts A., Younossi Z.M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008, 49:608-612.
10. Ratziu V., Bonyhay L., Di Martino V., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485-1493.
11. Sanyal A.J., Banas C., Sargeant C., et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006, 43:682-689.
12. Kojima H., Sakurai S., Matsumura M., et al. Cryptogenic cirrhosis in the region where obesity is not prevalent. World J Gastroenterol 2006, 12:2080-2085.
13. Yatsuji S., Hashimoto E., Tobari M., et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009, 24:248-254.
14. Ascha M.S., Hanouneh I.A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51:1972-1978.
15. Bhala N., Angulo P., van der Poorten D., et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011, 54:1208-1216.
16. Söderberg C., Stål P., Askling J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
17. Dam-Larsen S., Becker U., Franzmann M.B., et al. Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol 2009, 44:1236-1243.
18. Arase Y., Kobayashi M., Suzuki F., et al. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. Hepatol Res 2012, 42:264-272.
19. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
20. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
21. Ekstedt M., Franzén L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
22. Hashimoto E., Yatsuji S., Tobari M., et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009, 44(Suppl 19):89-95.
23. Kawamura Y., Arase Y., Ikeda K., et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol 2012, 107:253-261.
24. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349-1354.
25. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134-140.
26. Regimbeau J.M., Colombat M., Mognol P., et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004, 10:S69-S73.
27. Abe H., Yoshizawa K., Kitahara T., et al. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008, 43:967-974.
28. Paradis V., Zalinski S., Chelbi E., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009, 49:851-859.
29. Malik S.M., Gupte P.A., de Vera M.E., et al. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009, 7:800-806.
30. Sorrentino P., D'Angelo S., Ferbo U., et al. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol 2009, 50:351-357.
31. Ertle J., Dechêne A., Sowa J.P., et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2011, 128:2436-2443.
32. Tokushige K., Hashimoto E., Yatsuji S., et al. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C. J Gastroenterol 2010, 45:960-967.
33. Cho E.J., Kwack M.S., Jang E.S., et al. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area. Digestion 2011, 84(Suppl 1):17-22.
34. Tokushige K., Hashimoto E., Horie Y., et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol 2011, 46:1230-1237.
35. Takuma Y., Nouso K., Makino Y., et al. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol 2011, 26:1417-1424.
36. Yang J.D., Harmsen W.S., Slettedahl S.W., et al. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 2011, 9:617-623.
37. Wakai T., Shirai Y., Sakata J., et al. Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease. J Gastrointest Surg 2011, 15:1450-1458.
38. Hashimoto E., Taniai M., Kaneda H., et al. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2004, 28:164S-168S.
39. Donadon V., Balbi M., Ghersetti M., et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009, 15:2506-2511.
40. Cotrim H.P., Parise E.R., Oliveira C.P., et al. Nonalcoholic fatty liver disease in Brazil: clinical and histological profile. Ann Hepatol 2011, 10:33-37.
41. Zen Y., Katayanagi K., Tsuneyama K., et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001, 51:127-131.
42. Shimada M., Hashimoto E., Taniai M., et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154-160.
43. Mori S., Yamasaki T., Sakaida I., et al. Hepatocellular carcinoma with nonalcoholic steatohepatitis. J Gastroenterol 2004, 39:391-396.
44. Ikeda H., Suzuki M., Takahashi H., et al. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder. Pathol Int 2006, 56:40-45.
45. Cuadrado A., Orive A., García-Suárez C., et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg 2005, 15:442-446.
46. Hai S., Kubo S., Shuto T., et al. Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. Surg Today 2006, 36:390-394.
47. Iannaccone R., Piacentini F., Murakami T., et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 2007, 243:422-430.
48. Hashizume H., Sato K., Takagi H., et al. Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol 2007, 19:827-834.
49. Maeda T., Hashimoto K., Kihara Y., et al. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis. Hepatogastroenterology 2008, 55:1404-1406.
50. Guzman G., Brunt E.M., Petrovic L.M., et al. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?. Arch Pathol Lab Med 2008, 132:1761-1766.
51. Takamatsu S., Noguchi N., Kudoh A., et al. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. Hepatogastroenterology 2008, 55:609-614.
52. Chagas A.L., Kikuchi L.O., Oliveira C.P., et al. Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?. Braz J Med Biol Res 2009, 42:958-962.
53. Kawada N., Imanaka K., Kawaguchi T., et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009, 44:1190-1194.
54. Ohki T., Tateishi R., Shiina S., et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 2009, 58:839-844.
55. Smith B.M., Hussain A., Jacobs M., et al. Ruptured hepatocellular carcinoma in a patient with nonalcoholic steatohepatitis. Surg Obes Relat Dis 2009, 5:510-512.
56. Takuma Y., Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol 2010, 16:1436-1441.
57. Hessheimer A.J., Forner A., Varela M., et al. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2010, 22:1239-1244.
58. Yasui K., Hashimoto E., Komorizono Y., et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011, 9:428-433.
59. Stefano J.T., de Oliveira C.P., Corrêa-Giannella M.L., et al. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?. Liver Int 2011, 31:377-385.
60. Orikasa H., Ohyama R., Tsuka N., et al. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus. J Submicrosc Cytol Pathol 2001, 33:195-200.
61. Anagnostopoulos G.K., Arvanitidis D., Tsiakos S., et al. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?. J Clin Gastroenterol 2003, 37:88-89.
62. Gonzalez L., Blanc J.F., Sa Cunha A., et al. Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient. Semin Liver Dis 2004, 24:415-419.
63. Bullock R.E., Zaitoun A.M., Aithal G.P., et al. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol 2004, 41:685-686.
64. Kawai H., Nomoto M., Suda T., et al. Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World J Hepatol 2011, 3:15-23.
65. Ichikawa T., Yanagi K., Motoyoshi Y., et al. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis. J Gastroenterol Hepatol 2006, 21:1865-1866.
66. Bambha K., Belt P., Abraham M., et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012, 55:769-780.
67. Petitti D.B. Advanced issues in meta-analysis: Meta-analysis, decision analysis, and cost-effectiveness analysis 2000, Oxford University Press, New York. 2nd ed.
68. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
69. Hepatocellular carcinoma: United States, 2001-2006. MMWR Morb Mortal Wkly Rep 2010, 59:517-520. Centers for Disease Control and Prevention (CDC).